Purple Biotech
Focus: Purple Biotech is an Israeli small-molecule focused biotech company headquartered in Rehovot with a primary pipeline in cardiovascular and oncology indications. The company operates at an early-stage development phase with limited commercial scale.
Profile data last refreshed 5h ago · AI intelligence enriched 1w ago
Open Jobs
3
Should You Work at Purple Biotech?
AI assessmentPurple Biotech is a high-risk, early-stage oncology-focused biotech suitable for early-career professionals seeking hands-on drug development exposure but unsuitable for those requiring financial stability or clinical-stage certainty.
Why Work Here
- Commercial momentum: 2 of 3 active job openings are in Commercial roles, signaling market entry preparation for CONSENSI (launched product).
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak11.8yr
CONSENSI is Purple Biotech's only commercial-stage asset, approved via NDA with patent protection extending to 2038, providing the company's primary revenue base.
Help build intelligence for Purple Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.